Collaborate with the functional genomics screening laboratory

Apply to collaborate with the functional genomics screening laboratory (FGSL) on projects using complex human in vitro models for CRISPR screening to better understand model biology and enable target identification. The FGSL is a joint venture between MRC, AstraZeneca and the Milner Therapeutics Institute, University of Cambridge. It has been set up to enable UK based academic groups and where space allows UK based small medium enterprises and industry to have access to a state-of-the-art arrayed functional genomics screening laboratory. Screens will be carried out by scientists employed at Milner Therapeutics Institute (MTI), with all screens run as collaborations to ensure the best possible outcome and data. Applicants define the purpose of the screen and desired outcomes, providing the in vitro model, while the FGSL team conducts the screening work. Financial support for screens (consumables) is available either from AstraZeneca or from a screening access fund provided by MRC.